Terms: = Liver cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
396 results:
1. Clinical Analysis and in Vitro Correlation of bcrp-Mediated Drug-Drug Interaction in the Gastrointestinal Tract.
Perera LMB; Okazaki K; Woo Y; Takahashi S; Zhang X; Mizoi K; Takahashi T; Ogihara T
Biol Pharm Bull; 2024; 47(4):750-757. PubMed ID: 38556260
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
[TBL] [Abstract] [Full Text] [Related]
3. Sensitization of cholangiocarcinoma cells to chemotherapy through bcrp inhibition with β-caryophyllene oxide.
Ortiz-Rivero S; Peleteiro-Vigil A; Abete L; Lozano E; Hammer HS; Giacomo SD; Abad M; Boix L; Forner A; Reig M; Macias RIR; Pötz O; Marin JJG; Briz O
Biomed Pharmacother; 2024 Jan; 170():116038. PubMed ID: 38141281
[TBL] [Abstract] [Full Text] [Related]
4. A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).
Watanabe S; Furuya N; Nakamura A; Shiihara J; Nakachi I; Tanaka H; Nakao M; Minato K; Seike M; Sasaki S; Kisohara A; Takeuchi S; Honda R; Takamura K; Kagamu H; Yoshimura K; Kobayashi K; Kikuchi T
Eur J Cancer; 2024 Jan; 197():113469. PubMed ID: 38061214
[TBL] [Abstract] [Full Text] [Related]
5. Polyphyllin I attenuates the invasion and metastasis via downregulating GRP78 in drug-resistant hepatocellular carcinoma cells.
Du H; Wu H; Kang Q; Liao M; Qin M; Chen N; Huang H; Huang D; Wang P; Tong G
Aging (Albany NY); 2023 Nov; 15(21):12251-12263. PubMed ID: 37934581
[TBL] [Abstract] [Full Text] [Related]
6. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on toxicologically relevant gene expression profiles in a liver-on-a-chip model.
Solan ME; Schackmuth B; Bruce ED; Pradhan S; Sayes CM; Lavado R
Environ Pollut; 2023 Nov; 337():122610. PubMed ID: 37742859
[TBL] [Abstract] [Full Text] [Related]
7. Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry method.
Rysz MA; Kinzi J; Schäfer AM; In-Albon K; Zürcher S; Schmidlin S; Seibert I; Schwardt O; Ricklin D; Meyer Zu Schwabedissen HE
J Pharm Biomed Anal; 2023 Nov; 236():115716. PubMed ID: 37722165
[TBL] [Abstract] [Full Text] [Related]
8. Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1.
de With M; van Doorn L; Kloet E; van Veggel A; Matic M; de Neijs MJ; Oomen-de Hoop E; van Meerten E; van Schaik RHN; Mathijssen RHJ; Bins S
Clin Pharmacokinet; 2023 Nov; 62(11):1589-1597. PubMed ID: 37715926
[TBL] [Abstract] [Full Text] [Related]
9. Changes in Expression and Function of Placental and Intestinal P-gp and bcrp Transporters during Pregnancy.
Szatmári P; Ducza E
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685897
[TBL] [Abstract] [Full Text] [Related]
10. Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling.
He H; Guo J; Hu Y; Zhang H; Li X; Zhang J; Jin S
Acta Biochim Biophys Sin (Shanghai); 2023 Jul; 55(9):1404-1414. PubMed ID: 37489008
[TBL] [Abstract] [Full Text] [Related]
11. Identification of the Stapled α-Helical Peptide ATSP-7041 as a Substrate and Strong Inhibitor of OATP1B1 In Vitro.
Ishikawa R; Saito K; Misawa T; Demizu Y; Saito Y
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371582
[TBL] [Abstract] [Full Text] [Related]
12. Understanding the Mechanism and Extent of Transplacental Transfer of (-)-∆
Kumar AR; Sheikh ED; Monson JW; Ligon SE; Talley RL; Dornisch EM; Howitz KJ; Damicis JR; Ieronimakis N; Unadkat JD
Clin Pharmacol Ther; 2023 Aug; 114(2):446-458. PubMed ID: 37278090
[TBL] [Abstract] [Full Text] [Related]
13. Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2.
Elkateb AS; Nofal S; Ali SA; Atya HB
Inflammation; 2023 Aug; 46(4):1493-1511. PubMed ID: 37171695
[TBL] [Abstract] [Full Text] [Related]
14. Effect of Chronic Hepatitis C on the Activity of the Membrane Transporters P-gp and OATP1B1/bcrp on Patients With Different Stages of Hepatic Fibrosis.
Pippa LF; Vieira CP; Caris JA; Rocha A; Marques MP; Garcia CP; Rezende REF; Lanchote VL
Clin Pharmacol Ther; 2023 Jul; 114(1):173-181. PubMed ID: 37070971
[TBL] [Abstract] [Full Text] [Related]
15. ABCB1 and abcg2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in cancer Cell Lines.
Wu CP; Hung CY; Hsieh YJ; Murakami M; Huang YH; Su TY; Hung TH; Yu JS; Wu YS; Ambudkar SV
Cells; 2023 Mar; 12(7):. PubMed ID: 37048130
[TBL] [Abstract] [Full Text] [Related]
16. [Quantitative assessment of breast cancer resistance protein during pregnancy in rabbits].
Popova NM; Slepnev AA; Abalenikhina YV; Shchulkin AV; Rokunov ED; Yakusheva EN
Biomed Khim; 2023 Feb; 69(1):72-77. PubMed ID: 36857429
[TBL] [Abstract] [Full Text] [Related]
17. Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat liver and Intestinal Segments for Applications in PBPK Modeling.
Sharma S; Singh DK; Mettu VS; Yue G; Ahire D; Basit A; Heyward S; Prasad B
Mol Pharm; 2023 Mar; 20(3):1737-1749. PubMed ID: 36791335
[TBL] [Abstract] [Full Text] [Related]
18. The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism.
Granados JC; Ermakov V; Maity K; Vera DR; Chang G; Nigam SK
JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36692015
[TBL] [Abstract] [Full Text] [Related]
19. Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations.
Hamed AR; Yahya SMM; Nabih HK
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1117-1128. PubMed ID: 36651944
[TBL] [Abstract] [Full Text] [Related]
20. The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer.
Hjorth CF; Damkier P; Stage TB; Feddersen S; Hamilton-Dutoit S; Ejlertsen B; Lash TL; Bøggild H; Sørensen HT; Cronin-Fenton D
Cancer Chemother Pharmacol; 2023 Feb; 91(2):157-165. PubMed ID: 36598552
[TBL] [Abstract] [Full Text] [Related]
[Next]
